ACI American Conference Institute Business Information in a Global Context

Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics

In-house Insights from: • Allergan • Astellas • Boehringer Ingelheim • Depomed • Eagle Pharmaceuticals, Inc.

April 24–25, 2017 | Conrad New York | New York City, NY April 26, 2017: Post-Conference Workshops

11 th Annual Paragraph IV Disputes

• Eli Lilly and Company • Endo Pharmaceuticals • Gilead Sciences • GlaxoSmithKline • Ironwood Pharmaceuticals • Merck & Company • Novartis Pharmaceuticals Corporation • Pfizer Inc • Sandoz Inc. • Xellia


Key Agency Insights from: USPTO: Karin Ferriter Deputy Chief Policy Officer, Office of Policy and International Affairs FDA: Maryll W. Toufanian, J.D. Deputy Director, Office of Generic Drug Policy Office of Generic Drugs, CDER

Judicial Insights from: U.S. District Court Honorable Ruben Castillo Chief Judge Northern District of Illinois Honorable Jose L. Linares, U.S.D.J. District of New Jersey

Patent Trial and Appeal Board, USPTO Honorable Rama G. Elluru Administrative Patent Judge Honorable Brian P. Murphy Lead Administrative Patent Judge Honorable Kimberly McGraw Administrative Patent Judge

FTC: Daniel Butrymowicz Staff Attorney Federal Trade Commission (Washington, DC)

Honorable Tonianne Bongiovanni, U.S.M.J. District of New Jersey Honorable Christopher J. Burke, U.S.M.J. District of Delaware Honorable Roy Payne, U.S.M.J. Eastern District of Texas

Supporting Sponsors:

Associate Sponsors:

Cocktail Reception Sponsor:

Luncheon Sponsor:


Sponsored By:

a C5 Group Company Business Information in a Global Context

Register Now | 888 224 2480 | AmericanConference.com/PIVDisputes

Made with FlippingBook Online newsletter